Prescription drug · ANDA
Prednisolone NDC 0121-0885
Prednisolone 15 mg/5mL · Solution · Oral · PAI Holdings, LLC dba PAI Pharma
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0121-0885-08 | 00121088508 | 240 mL in 1 BOTTLE (0121-0885-08)Marketed from Sep 12, 2023 | |
| 0121-0885-16 | 00121088516 | 480 mL in 1 BOTTLE (0121-0885-16)Marketed from Sep 12, 2023 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Prednisolone
- Generic name (nonproprietary)
- prednisolone
- Active ingredients
- Prednisolone — 15 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- PAI Holdings, LLC dba PAI PharmaNDC labeler code 0121
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040571
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 0121-0885_1166b85b-73c5-4a8f-bc41-f99b406d0ff5SPL ID 1166b85b-73c5-4a8f-bc41-f99b406d0ff5SPL set ID cebd7b5b-8e9f-4de9-9fcf-8ee0661fede3RxCUI 283077UNII 9PHQ9Y1OLMUPC 0301210885082
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400121088508followed by a unit qualifier and the quantityPackage 00121-0885-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Prednisolone Oral Solution USP is indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable: in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis, including juvenile rheumatoid arthritis (sel…
Excerpt only. Read the full label for complete information.
About NDC 0121-0885
- What is NDC 0121-0885?
- 0121-0885 is the product NDC for Prednisolone, Prednisolone 15 mg/5mL solution, listed with the FDA by PAI Holdings, LLC dba PAI Pharma. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Prednisolone.
- What is the active ingredient?
- Prednisolone.
- Who is the labeler?
- PAI Holdings, LLC dba PAI Pharma, NDC labeler code 0121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Prednisolone?
- 11 other product NDCs are listed under this name. See all Prednisolone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Prednisolone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Prednisoloneprednisolone oral | Prednisolone 15 mg/5mL | SolutionOral | TRUPHARMA, LLC | 52817-860 | 52817-0860-0852817-0860-16 |
| Prednisoloneprednisolone oral | Prednisolone 15 mg/5mL | SolutionOral | Tulex Pharmaceuticals Inc | 70404-077 | 70404-0077-1470404-0077-16 |
| Prednisoloneprednisolone oral solution | Prednisolone 15 mg/5mL | SolutionOral | Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. | 23155-927 | 23155-0927-5123155-0927-52 |
| Prednisolone | Prednisolone 5 mg/1 | TabletOral | Hisun Pharmaceuticals USA, Inc. | 42658-160 | 42658-0160-05 |
| Prednisolone | Prednisolone 5 mg/1 | TabletOral | Zhejiang Xianju Pharmaceutical Co., Ltd. | 60722-5011 | 60722-5011-0060722-5011-01 |
| Prednisolone | Prednisolone 15 mg/5mL | SolutionOral | A-S Medication Solutions | 50090-7115 | 50090-7115-0050090-7115-01 |
| Prednisolone | Prednisolone 5 mg/1 | TabletOral | Aurobindo Pharma Limited | 59651-491 | 59651-0491-0159651-0491-50 |
| Prednisoloneprednisolone oral | Prednisolone 15 mg/5mL | SolutionOral | Chartwell Governmental & Specialty RX, LLC. | 68999-250 | 68999-0250-24 |
| Prednisoloneprednisolone oral | Prednisolone 15 mg/5mL | SolutionOral | Chartwell RX, LLC | 62135-250 | 62135-0250-2462135-0250-3762135-0250-47 |
| PrednisoLONE | Prednisolone 15 mg/5mL | SyrupOral | Lannett Company, Inc. | 0527-5406 | 00527-5406-6800527-5406-70 |
Other NDCs under ANDA 040571
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Prednisolone | Prednisolone 15 mg/5mL | SolutionOral | A-S Medication Solutions | 50090-7115 |